The Commonwealth of Virginia will receive an estimated 480,000 doses of COVID-19 vaccine from two manufacturers (Pfizer and Moderna) by the end of December.
This initial distribution will ensure 480,000 health care personnel (HCP) and long-term care facility (LTCF) residents receive a first dose of the vaccine, beginning the inoculation process for nearly all members of Virginia’s two top-priority groups. The Virginia Department of Health (VDH) estimates that there are up to 500,000 HCP and LTCF residents in Virginia.
“Vaccine will be provided to Virginians in a way that is fair, ethical,\ and transparent,” said Dr. M. Norman Oliver, Virginia’s state health commissioner. “We will focus initially on the groups that have been most at risk for severe illness from COVID-19 infections and those whose work puts them at greatest risk of contracting COVID-19 infections. Over time, as more vaccine supply becomes available, more Virginians will be able to get vaccinated, and we can look forward to a time when this pandemic will end.”
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices’ (ACIP) on Tuesday, Dec. 1, voted to formally recommend HCP and LTCF residents as the top priorities for vaccination. In response, the Virginia Disaster Medical Advisory Committee (VDMAC) and the Virginia Unified Command voted this week to officially adopt ACIP recommendations in Virginia and provide initial vaccines to both HCP and LTCF residents.
The first shipment of vaccines is expected to be received from Pfizer in mid-December and will require ultracold storage (negative 70 degrees Celsius). All 72,150 initial doses will be distributed directly to geographically diverse health care systems with ultracold storage capacity and will go to HCP. Health care personnel that directly care for COVID-19 patients will receive top priority among health care providers.
Subsequent weekly shipments are expected to begin after the initial shipment and will be divided among HCP and LTCF residents. The majority of LTCF in Virginia will receive vaccinations from CVS and Walgreens’ teams onsite through a federal CDC-pharmacy-LTCF partnership. Health care systems and public health will ensure access to vaccination for all HCP and LTCF residents equitably across the entire state.
According to ACIP, as of December 1, 2020, approximately 245,000 COVID-19 cases and 858 COVID-19-associated deaths had been reported among U.S. HCP. Early protection of HCP is critical to preserve capacity to care for patients with COVID-19 or other illnesses. LTCF residents, because of their age, high rates of underlying medical conditions, and congregate living situation, are at high risk for infection and severe illness from COVID-19. As of November 15, 2020, approximately 500,000 COVID-19 cases and 70,000 associated deaths had been reported among residents of skilled nursing facilities in the United States.
Health care personnel are defined as paid and unpaid persons serving in health care settings who have the potential for direct or indirect exposure to patients or infectious materials. Long-term care facility residents are defined as adults who reside in facilities that provide a variety of services, including medical and personal care, to persons who are unable to live independently.
The actual amount of vaccine received in Virginia is a moving target and is dependent on when and how quickly vaccination doses are manufactured. VDH is coordinating future prioritization based on federal guidance.
